Functional gastrointestinal disorders, or disorder of gut-brain interaction, can be frightening to many GIs. How do I talk to the patient? What can I tell them if there is no improvement in their symptoms? How can I even explain to them what their diagnosis is, if I don’t even know it?
To clear things up and provide clear points of action, our host Egle Dieninyte talked to Tim Vanuytsel from the University Hospital in Leuven, Belgium.

In the second part of our short two-part series on complications (not only in endoscopy, but also in doctor-patient communication), Srisha Hebbar and Pradeep Mundre sit down again to focus on the patient perspective, serious complications and the psychological aspect of complications.

Complications, not only in endoscopy but also in doctor-patient communication, are something that every experienced gastroenterologist has encountered. To talk us through this, our host Pradeep Mundre has invited Srisha Hebbar, a consultant gastroenterologist from the UK and host of the first national symposium on complications in endoscopy.
The second part of this episode will be released on May 28 st 2025.

Hot off the press: The BOSS (Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study) randomised control study.
Is surveillance really not affecting survival in oesophageal cancer patients? To put things into perspective, we asked Massimiliano Di Pietro, UEG Talks podcast veteran and oesophageal cancer expert, to guide us through these exciting new results. Hosted by Pradeep Mundre, this bonus episode, combined with our previously released two-part series on oesophageal cancer (also with Massimiliano Di Pietro), covers everything you should know about oesophageal cancer.

The ESGE days 2025 from the 3rd to the 5th of April have ended. Interviewed at the conference, (now former) ESGE president Ian Gralnek shares his insights on the ESGE days program, the future of endoscopy, airline pilots and English & Lithuanian proverbs.
*In the beginning of the episode, Egle is talking about the ESGE days, not UEG Week 2025, which is happening on October 4-7.

In this episode of UEG Talks, host Egle and co-host Charles Murray sit down with Alexander Goldowsky, a gastroenterologist and gut microbiome expert, to explore the unique healthcare challenges faced by sexual and gender minority (SGM) groups. They discuss the stigma and discrimination that impact SGM patients, the broader implications for their health, and the urgent need for greater awareness, education, and advocacy in gastroenterology. Alexander also introduces Rainbows in Gastro, a pioneering initiative aimed at improving SGM healthcare within the field, and highlights the role of individual responsibility in driving meaningful change.
https://rainbowsingastro.org/

In this second part of our short two-part series on oesophageal cancer, our host, Pradeep Mundre, continues his conversation with Massimiliano Di Pietro about the risk factors of Barrett’s oesophagus, the role of proton-pump inhibitors, surveillance strategies and some future directions of oesophageal cancer research.

In the first part of this two-part series, our host, Pradeep Mundre, talks to oesophageal cancer expert Massimiliano Di Pietro about the epidemiology and treatment of oesophageal cancer, how this has changed over time and if there is potential for prevention. The second part of this episode will be released on March 5th.

During UEG Week 2024, the president of ESGE, Ian Gralnek, was approached by our host, Egle Dieninyte, for a surprise interview. The conversation turned out to be so delightful that we decided to publish it as a full episode on our UEG Talks channel. We won’t spoil the details, so be sure to tune in!

In this episode of the UEG Talks conversation between Maria Vehreschild and Pradeep Mundre, we delve into the complexities of the faecal microbiome and the role of faecal microbiota transplantation (FMT) in treating various diseases, particularly C. difficile infections and inflammatory bowel disease (IBD). The discussion covers the historical context of FMT, its mechanisms of action, current treatment guidelines, safety considerations, and the various delivery methods. The conversation also emphasises the need for further research and the importance of professional standards in FMT practices.